LH inks new agreement to acquire BioReference Health's oncology and related clinical testing services businesses.

周四，H.C. Wainwright重申对Opko Health（NASDAQ:OPK）的买入评级，维持目标价$3.00不变，相较当前股价$1.78具有显著上涨空间。此评级确认是在Opko ...

The independent laboratory company has entered an agreement to acquire BioReference Health's oncology diagnostic services.

Labcorp will acquire the oncology diagnostics operations from BioReference Health as part of a push to expand in high-growth ...

Labcorp (LH) and OPKO Health (OPK) announced earlier on Tuesday that they have entered into an agreement for Labcorp to acquire select assets ...

The deal is part of BioReference's ongoing effort to streamline its business to achieve profitability and follows the sale last year of clinical laboratory assets to Labcorp.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Labcorp (LH) and OPKO Health (OPK) announced that they have entered into an agreement for Labcorp to acquire select assets of BioReference ...

Labcorp has entered into an agreement to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO ...

Labcorp, Opko Health acquire certain assets of BioReference Health Labcorp price target raised to $290 from $260 at Argus Target reports Q4 beat, Walgreens reportedly near go-private deal: Morning ...

(Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health ...